form  kite pharma inc for jun  filed by kim helen susan research stocks news story skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  news  events  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print format change text size default text sizea larger text sizea largest text sizea form  kite pharma inc for jun  filed by kim helen susan by k wizard—  pm et  httparchivefastedgarcomaizgcwzczzzotmzrz filed on june   more kite news briefkite pharma inc says plans to initiate phase  of zuma trial in  reuters   am et  kite to launch midstage leukemia trial in fourth quarter  reuters   am et  kite reports  percent of patients achieved mrd negative complete remission in updated analysis from phase  zuma cart trial of ktec in adult patients with high burden relapsedrefractory acute lymphoblastic leukemia business wire   am et  copyright – fmr llc  all rights reserved  terms of use privacy security site map  stock market research top stocks quotes  news  fidelity investments skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window stock research  ideas you are here stock research center my research screen  filter stock screeners preset expert strategies news  insights events calendar upgrades  downgrades explore firm research research firms research firm scorecards reports search related resources fidelity learning center us markets global markets sectors  industries stock research center not a fidelity customer no problem try our research for free without opening an account   trending stocks market movers top rated by sector orders by fidelity customers filters refresh equity summary score provided by starmine investing insights technical events provided by recognia as of  methodology recognia methodology bullish and bearish events of the day provide longshort trading ideas by identifying us stocks that have recently formed a bullish or bearish classic chart pattern patterns must have taken at least  days to form which draws out the more significant patterns for intermediate or longterm trend direction the list is then filtered to include stocks with a minimum  for bullish and  for bearish close price and a minimum  trading volume most recent patterns are listed first patterns on the same date are sorted using recognias proprietary quantitative algorithm to draw strong companies to the top and if further sorting is required for stocks with the same quantitative analysis result it is done by trading volume to draw highest volume stocks to the top vly log in for events bac tgna wafd hafc mcf log in for events ati rpd hil cdxs find out how to use fundamental analysis and technical analysis when evaluating stocks with the help of the fidelity learning center my research –  organize and track your favorite securities get started todays events as of  am et  earnings  dividends  splits  upgrades  downgrades  economic  upcoming webinar events visit the learning center events page for a full list of upcoming webinars the equity summary score is provided for informational purposes only does not constitute advice or guidance and is not an endorsement or recommendation for any particular security or trading strategy the equity summary score is provided by thomson reuters starmine an independent company not affiliated with fidelity investmentsgics® global industry classification standards is an industry classification system developed by standard  poors in collaboration with morgan stanley capital international msci sp uses gics to determine the market segment to which a company is assignednews commentary including related symbols and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their usestock markets especially foreign markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments sector funds can be more volatile because of their narrow concentration in a specific industrysystem availability and response times may be subject to market conditionsthe fidelity screeners are research tools provided to help selfdirected investors evaluate securities the criteria and inputs entered are at the sole discretion of the user and all screens or strategies with preselected criteria are solely for the convenience of the user information supplied or obtained from the screeners is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell securities or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy or approach to screening or evaluating stocks preferred securities exchange traded products or closed end funds fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their use determine which securities are right for you based on your investment objectives risk tolerance financial situation and other individual factors and reevaluate them on a periodic basis copyright – fmr llc  all rights reserved  terms of use privacy security site map  kite stock news  fidelity skip to main content site navigation fidelitycom home customer service open an account refer a friend log in customer service open an account refer a friend log out search fidelitycom accounts  trade portfoliolog in required account positionslog in required tradelog in required active trader prolog in required transferlog in required cash managementlog in required billpaylog in required full viewlog in required profilelog in required account featureslog in required statementslog in required tax information retirement distributionslog in required offer see our featured trading offer learn more planning  advice what we offer financial basics building savings managing  growing wealth retirement life events news  research news watch listlog in required quotes alertslog in required mutual funds stocks fixed income bonds  cds etfs options markets  sectors ipos annuities learning center notebook notebook investment products mutual funds retirement  iras trading stocks fixed income bonds  cds etfs options sector investing cash management  credit cards managed accounts fidelity go  college savings annuities life insurance  long term care why fidelity the fidelity advantage planning  advice trading straightforward pricing insights  tools security  protection customer service open an account refer a friend log in customer service open an account refer a friend log out content and data provided by various third parties and fidelity − terms of use research  stocks  stock details enter company or symbol press down arrow for suggestions or escape to return to entry field view this information for the company or symbol snapshot detailed quote adv chart  technical news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings view this information for the company or symbol snapshot detailed quote advanced chart news analyst reports find symbol opens in new window snapshot detailed quote advanced chart  technical analysis news  events compare analyst opinions research reports key statistics earnings dividends ownership  insiders financial statements sec filings related resources stock research overview stock screeners markets  sectors fidelity learning center print  helpglossary helpglossary news  eventskite kite pharma inc    as of pm et  quotes delayed at least  min log in for real time quote add to watch list set alert hypothetical trade option chain price history download to csv file download to excel file log in for more news expand all collapse all alpine immune sciences inc completes merger with nivalis therapeutics inc business wire –  am et   commences trading on nasdaq global market on july   under ticker symbol “alpn”   utilizes novel proteinbased immunotherapy discovery platform focused on developing therapeutics for the potential treatment of inflammatory diseases and cancer   approximately  million in cash and cash equivalents on balance sheet following transaction close  seattle alpine immune sciences kite highlights durable complete remissions up to  months in patients with chemorefractory aggressive nonhodgkin lymphoma nhl after anticd car tcell therapy at the national cancer institute business wire –  am et  kite pharma kite inc  a leading cell therapy company highlighted the recent online publication of results in molecular therapy from a national cancer institute study of anticd chimeric antigen receptor tcell therapy in patients with aggressive nhl including diffuse large bcell lymphoma nivalis therapeutics announces results of special meeting of stockholders business wire –  am et  nivalis therapeutics inc nvls announced today that based upon the final vote count certified by the independent inspector of elections for the special meeting of stockholders held july   its stockholders approved all of the mergerrelated proposals including the agreement and plan of merger and reorganization dated as of april   by and among nivalis nautilus merger sub inc  tcell cancer therapy holds promise longerterm results await reuters –  am et  a novel cell treatment that saved the life of yearold austin schuetz was given the green light by us regulatory advisers on wednesday and doctors hope it can save the lives of more children with the most common type of childhood cancer us fda panel backs novartis pioneering new cancer gene therapy reuters –  pm et  novartis ags pioneering new cancer drug won enthusiastic support from a federal advisory panel on wednesday paving the way for approval of the first us gene therapy the panel unanimously recommended that the food and drug administration approve the drug tisagenlecleucel for patients ages  to  with relapsed bcell acute lymphoblastic leukemia the most common form of us childhood cancer pioneering cancer gene therapy by novartis backed by us panel reuters –  pm et  novartis ags pioneering cancer drug won the backing of a federal advisory panel on wednesday paving the way for the first gene therapy to be approved in the united states novartis readies for fda review of  bln cart child cancer hope reuters –  am et   fda to review novartiss ctl on wednesday  novartis poised to beat kite juno in cart race  key drug component inventors long unacknowledged by john miller two decades ago in a memphis tenn hospital lab cancer scientist dario campana and his team were hunting for a new way to fight deadly acute lymphoblastic leukemia stocks under scanner in the biotech space  achillion pharma kite pharma acorda therapeutics and tesaro pr newswire –  am et  new york july   if you want a stock review on achn kite acor or tsro then come over to httpdailystocktrackercomregister and sign up for your free customized report today httpdailystocktrackercomregister achillion pharma  on wednesday shares in new haven connecticut headquartered achillion pharmaceuticals inc achn recorded a trading volume of  million shares which was  us patent office to confirm kite’s seminal eshhar cart patent business wire –  am et  kite pharma inc kite a leading cell therapy company today announced that the united states patent and trademark office has provided a notice of intent to issue an ex parte reexamination certificate that confirms the patentability of amended claims presented in us patent no  known as the eshhar  patent kite named to the mit technology review’s annual  smartest companies list in recognition for its leadership in establishing cart therapy business wire –  am et  kite pharma inc kite a leading cell therapy company has been named to mit technology reviews  list of  smartest companies the companies on the list combine a high level of technology innovation with a business model that will help them make the most of it said nanette byrnes senior editor for business of mit technology review briefjuno therapeutics says court decides it lacks jurisdiction over kite pharma lawsuit reuters –  am et  juno therapeutics inc juno  court decides it lacks jurisdiction before fda approval occurs  juno therapeutics juno  us district court for district of delaware decided it lacked jurisdiction at this time over a lawsuit filed against kite pharma alpine immune sciences announces presentation of preclinical data showing potency of its firstgeneration dual icos and cd antagonist vigds in an animal model business wire –  am et  company plans to file ind in  for first in class molecule alpine immune sciences inc a biotechnology company developing a nextgeneration immune modulation platform today announced results from a preclinical study evaluating firstgeneration variant ig domains from the company’s lead program alpn juno therapeutics stock drops  after btig downgrades to sell marketwatch –  am et  juno therapeutics inc juno shares dropped  in premarket trade thursday after btig downgraded it to sell from neutral with a  price target juno shares closed at  on wednesday the company is trailing competitors like kite pharma inc kite and novartis ag nvs to market and there is little demonstrative proof that juno drugs work better or have fewer lifethreatening side effects btig analyst dane leone said novartis touts new tcell therapy data in race for fda approval reuters –  am et  novartis on wednesday touted new data from its tcell therapy ctl saying it is on a par with results of experimental molecules from kite pharma kite and juno therapeutics juno that also target aggressive blood cancers blood and bone marrow therapies grab spotlight at worlds top cancer meeting reuters –  am et  promising new data on blood and bone marrow cancer therapies that reengineer immune system cells are convincing more doctors of the validity of the approach according to reuters interviews at the worlds biggest annual oncology meeting kite to present at june  investor conferences business wire –  am et  kite pharma inc kite a leading cell therapy company today announced that management will present at two investor conferences in june  a live audio webcast of each event will be available on the investors section of kites website wwwkitepharmacom about kite kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid briefkite pharma inc says plans to initiate phase  of zuma trial in  reuters –  am et  kite pharma inc kite  kite reports  percent of patients achieved mrd negative complete remission in updated analysis from phase  zuma cart trial of ktec in adult patients with high burden relapsedrefractory acute lymphoblastic leukemia  kite pharma inc kite says plans to initiate phase  of zuma trial in  kite to launch midstage leukemia trial in fourth quarter  reuters –  am et  kite pharma inc kite said on monday it planned to launch in the fourth quarter of this year a phase  trial of its experimental tcell therapy in leukemia patients possibly at a lower dose than is currently being tested kite reports  percent of patients achieved mrd negative complete remission in updated analysis from phase  zuma cart trial of ktec in adult patients with high burden relapsedrefractory acute lymphoblastic leukemia business wire –  am et  santa monica calif in the phase  trial  patients were treated with ktec at two target dose levels the majority of adult patients diagnosed with all will experience disease relapse and subsequently face a poor prognosis said david chang md phd executive vice president research and development and chief medical officer of kite chinese cell therapy effective in small multiple myeloma trial reuters –  am et  a small trial conducted in china found that an experimental therapy using altered cells to recruit the bodys immune system to attack cancer can induce remission in most patients with advanced multiple myeloma a blood plasma cancer page page   next  todays and upcoming events aug  kite to announce q earnings before market unconfirmed past events last  days jun  shareholders meeting data provided by wall street horizon inc   technical events classic patterns past  days provided by recognia inc log in for trading events view all technical analysis in advanced chart technical analysis provided by trading central log in for trading events as with all your investments through fidelity you must make your own determination whether an investment is appropriate for you fidelity is not recommending or endorsing this security by making it available to customers you should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase before investing you should read the prospectus offering circular indenture or similar document carefully for a full description of the product including its features and risks to determine whether it is an appropriate investment for your investment objectives risk tolerance financial situation and other individual factors and be sure to reevaluate those factors on a periodic basisperformance data shown represents past performance which is no guarantee of future results current performance may be higher or lower than the performance data quoted yield and return will vary therefore you may have a gain or loss when you sell your sharesstock markets are volatile and can decline significantly in response to adverse issuer political regulatory market or economic developments growth stocks can be more volatile than other types of stocks value stocks can continue to be undervalued by the market for long periods of time foreign securities are subject to interestrate currencyexchangerate economic and political risks all of which are magnified in emerging markets illiquidity is an inherent risk associated with investing in real estate and reits there is no guarantee the issuer of a reit will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid closedend funds can trade at a discount to their nav shareholders of master limited partnerships may be treated as partners for tax purposes partnerships issue a schedule k form  rather than a form  form for tax purposes it lists the partners share of income deductions credits etc speak with your tax advisor to determine how this may affect you a royalty trust is a type of corporation mostly in the united states or canada usually involved in oil and gas production or mining royalty trusts may have special tax treatment so you should consult a tax advisor on the potential tax consequences of investing in themnews commentary and events are from thirdparty sources unaffiliated with fidelity fidelity does not endorse or adopt their content fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from their useany data charts and other information provided on this page are intended for research purposes to help selfdirected investors evaluate many types of securities including but not limited to common stocks american depository receipts master limited partnerships real estate investment trusts traditional preferred stock trust preferred securities thirdparty trust certificates convertible securities mandatory convertible securities and other exchangetraded equity andor debt securities criteria and inputs entered including the choice to make security comparisons are at the sole discretion of the user and are solely for the convenience of the user analyst opinions ratings and reports are provided by thirdparties unaffiliated with fidelity all information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance an offer of or a solicitation of an offer to buy or sell a security or a recommendation or endorsement by fidelity of any security or investment strategy fidelity does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating individual securities fidelity makes no guarantees that information supplied is accurate complete or timely and does not provide any warranties regarding results obtained from its use copyright – fmr llc  all rights reserved  terms of use privacy security site map  see the latest features personalizedget relevant information about your holdings right when you need itsee your performance click the portfolio icon to get information about stocks you own without leaving the research pagefaster access to positions a shortcut to view the full list of positions in your portfolio yes please use the ticker search boxadd your own notes use notebook to save your investment ideas in one convenient private and secure place convenient for youresearch thats clear accessible and all in one place makes for a better experienceonestop shop see everything you need to make investment decisions right in the dashboardaccess anywhere no matter where you are use the stock research experience across multiple devicesnew ideas on the ready find new ideas using quick links to the stock screener new ways to researchdiscover new tools to add or diversify your existing research strategystocktwits read live tweets from the financial and investing community about the stock youre interested infundamental analysis save time on research by getting an overall assessment of a companys valuation quality growth stability and financial healthrecognia technical analysis perfect for the technical trader—this indicator captures a stocks technical events and converts them into short medium and longterm sentimenttop competitors see how a stock measures up by instantly comparing it to the industry average and its top four competitorssocial sentiment get a sense of peoples overall feelings towards a company in social media with this summary toolearnings data monitor earnings expectations over the past three quarters and model a stocks price based on its pe helen susan kim  ceo founder businessman  profile directorpedianet  list of ceos founders board members and company directors helen susan kim check out list of companies and businesses related to helen susan kim find out helen susan kim address and contact details view other people related to helen susan kim  coworkers colleagues companions etc address  bay center place hayward  ca companies related to helen susan kim cikcompany namepositioncompany addresssunesis pharmaceuticals incdirector  oyster point boulevard suite  south san francisco kosan biosciences incpresident and ceo  bay center place hayward kite pharma incevp business development  colorado avenue santa monica  helen susan kim on the web persons related to helen susan kim  sunesis pharmaceuticals incnamepositioncitydaniel c md adelmansr vp research  development south san franciscodaniel c md adelmansr vp development and cmo south san franciscoalta biopharma management iii llcsan franciscoalta biopharma partners iii gmbh  co beteiligungs kgsan franciscoalta biopharma partners iii lp owner san franciscoalta embarcadero biopharma partners iii llcsan franciscowendell g van auken iiimenlo parkm james barrettbaltimorem james barrett owner timoniumpeter j barrisbaltimorepeter j barris owner timoniumforest baskett owner baltimoreforest baskett owner timoniumbay city capital fund llc owner san franciscobay city capital fund v coinvestment fund lpsan franciscobay city capital fund v coinvestment fund lpsan franciscobay city capital fund v lpsan franciscobay city capital fund v lpsan franciscobay city capital llc owner san franciscobay city capital management v llcsan franciscobay city capital management v llcsan franciscobiogen idec inc owner cambridgebiogen idec ma inccambridgeeric bjerkholtevp cfo  corp secretary palo altoeric bjerkholtsr vp corp dev  finance south san franciscoeric bjerkholtsouth san franciscoeric bjerkholtsr vp corp dev  finance south san franciscoeric bjerkholtchief financial officer south san franciscoeric bjerkholtevp cfo  corp secretary south san franciscosteve carchedidirector south san franciscofarah champsisan franciscofarah champsisan franciscofarah champsisan franciscoadam r craigevp development  cmo new yorkadam r craigevp development  cmo south san franciscosuisse credit owner new yorkcredit suisse first boston advisory partners llcnew yorkcredit suisse first boston bermuda ltdnew yorkcredit suisse first boston equity partners bermuda lpnew yorkcredit suisse first boston equity partners lpnew yorkcredit suisse first boston us executive advisors lpnew yorkyogen k dalalmenlo parkswisher danielsouth san franciscoswisher danielsouth san franciscostump davidrockvillemisfeldt daytonsan franciscojean deleagesan franciscojean deleagesan franciscojoseph i depintoevp cco south franciscoryan d drant owner baltimoreryan d drant owner timoniumhurwitz edsouth san franciscohurwitz edsan franciscoema partners fund  lpnew yorkema private equity fund  lpnew yorkbjerholt ericsouth san franciscobjerkholt ericsouth san franciscoanthony b evnindirector new yorkanthony b evnindirector new yorkstephen p a fodordirector south san franciscostephen p a fodordirector south san francisco cakevin a fongmenlo parkmatthew fustdirector south san franciscomatthew fustdirector south san francisco camatthew fustdirector south san franciscosteven d goldbydirector south san franciscogrowth equity opportunities fund llc owner baltimoregrowth equity opportunities fund llc owner timoniuma grant heidrich iiimenlo parkkim helensouth san franciscohemisphere private equity partners charitable trusthamiltonhemisphere private equity partners ltdhamiltonrussell c hirschsouth san franciscopearce homersouth san franciscoedward hurwitzdirector san franciscoedward hurwitzdirector south san franciscoyoung jamesmenlo parkyoung jamessouth san franciscopatrick j kerins owner baltimorepatrick j kerins owner timoniumsteven b ketchumdirector palo altosteven b ketchumsouth san franciscosteven b ketchumsenior vice president rd south san franciscosteven b ketchumdirector south san franciscohelen susan kimdirector haywardhelen susan kimdirector south san franciscokrishna kittu kolluri owner baltimorekrishna kittu kolluri owner timoniumc richard kramlichbaltimorec richard kramlichtimoniumjonathan s leffdirector south san franciscocharles m linehan owner baltimorealix marduelsan franciscofust matthewemeryvillemayfield associates fund iii l pmenlo parkix mayfield owner menlo parkmayfield ix management llcmenlo parkmayfield viii management llcmenlo parkrobert scott mcdowellvice president research south san franciscodayton misfeldtdirector san franciscodayton misfeldtdirector south san franciscofrank g myers jrmenlo parknea  gp llcbaltimorenea  gp llctimoniumpartners  limited partnership neabaltimorepartners  limited partnership neatimoniumenterprise associates  limited partnership newbaltimoreenterprise associates  limited partnership newtimoniumcharles w newhall iiibaltimorecharles w newhall iiitimoniumgeoffrey m parkerdirector carlsbadhomer l pearcedirector south san franciscohomer l pearcedirector south san franciscoedward penhoetsan franciscoedward penhoetsan franciscomark w perrybaltimoremark w perrytimoniumvalerie l piercesr vp gc  corp secretary south san franciscovalerie l piercesvp  general counsel south san franciscoscott d sandellbaltimorescott d sandell owner timoniumdominique semon owner new yorkketchum stevensouth san franciscoketchum stevensouth san franciscodavid c stumpdirector rockvilledavid c stumpdirector south san franciscodavid c stumpdirector south san franciscodaniel n swisher jrpresident and ceo south san franciscodaniel n swisher jrpresident  ceo south san franciscodaniel n swisher jrpresident and ceo south san franciscodaniel n swisher jrpresident and ceo south san franciscodaniel n swisher jrpresident and ceo south san franciscodaniel n swisher jrpresident and ceo south san franciscoeugene a trainor iii owner baltimorewilliam d ungermenlo parkwarburg pincus  conew yorkwarburg pincus  conew yorkwarburg pincus  conywarburg pincus equity partners lp owner new yorkwarburg pincus equity partners lpnew yorkwarburg pincus llcnew yorkwarburg pincus llcnew yorkwarburg pincus partners llcnew yorkwarburg pincus partners llcnew yorkjames a wellsdirector south san franciscodaryl b wintersvpgen counselcorp secretary south san franciscodaryl b wintersvp of ipcorp secretary south san franciscojames w youngdirector seattlejames w youngexecutive chairman south san franciscojames w youngexecutive chairman south san franciscojames w youngexecutive chairman south san franciscojames w youngdirector south san franciscopersons related to helen susan kim  kosan biosciences incnamepositioncitybruce a md chabnerdirector haywardkevan clemensdirector haywardkevan clemensdirector haywardpamela sarah cohenchief medical officer haywardpeter phd davisdirector haywardjager robert desvp chief medical officer haywardjean deleagedirector haywardjean deleagedirector san franciscocharles j homcydirector haywardmargaret a hornsvp general counsel haywarddavid louis johnsonhaywardrobert g md phd johnson jrrobert g md phd johnson jrpresident and ceo haywardsusan m kanayasr vp finance and cfo haywardchaitan phd khoslachaitan phd khosladirector haywardhelen susan kimpresident and ceo haywardpeter licarisvp manufacturing  operations haywardbruce e macmillansvp general counsel haywardmichael s ostrachmichael s ostrach haywarddaniel v md phd santi owner haywardpieter b timmermanssvp drug disc  preclin dev haywardgary titussr vp and cfo haywardchristopher t phd walshdirector haywardjonathan k wrightsvp and general counsel haywardpersons related to helen susan kim  kite pharma incnamepositioncitybelldegrun arielos angelesbelldegrun ariesanta monicajakobovits ayalos angelesarie belldegrunchairman president and ceo los angelesarie belldegrunchairman president and ceo santa monicamarc bettervp product sciences santa monicadavid bondermandirector david bondermandirector santa monicacynthia m butittachief operating officer cynthia m butittacoo and cfo santa monicafarah champsidirector san franciscofarah champsidirector santa monicadavid d changevp rd chief medical off santa monicaian t clarkdirector so san franciscobutitta cynthiasanta monicabonderman davidlos angelesbonderman davidsanta monicaroy doumanidirector veniceroy doumanidirector santa monicachampsi farahlos angeleschampsi farahsanta monicalee glorialos angelesfranz b humerdirector new yorkpaul l jenkinsonchief financial officer santa monicapeacock jonathansanta monicakazam joshualos angeleskazam joshuasanta monicajoshoa a kazamdirector new yorkjoshua a kazamdirector santa monicanolop keithsanta monicahelen susan kimevp business development haywardbetter marcsanta monicaroberts margosanta monicatimothy l mooreevp technical operations santa monicaran nussbaumdirector santa monicajonathan m peacockdirector thousand oaksjonathan m peacockdirector santa monicanussbaum ranlos angelesnussbaum ransanta monicasproule rizwanasanta monicamargo r robertschief scientific officer santa monicadoumani roylos angelesdoumani roysanta monicasteven b ruchefskydirector flemingtonsteven b ruchefskydirector santa monicarizwana f sproulevp regulatory affairs santa monicaruchefsky stevenlos angelesruchefsky stevensanta monicashawn tomasellochief commercial officer sunnyvalejeffrey wiezoreksvp clinical development santa monicajeffrey wiezorekvp clinical development santa monicaowen n wittedirector santa monica insider trading  kim helen susan  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  kim helen susan select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm kite pharma inc kite kim helen susanevp business development    direct view sale  pm kite pharma inc kite kim helen susanevp business development    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana kite pharma inc kite kim helen susanevp business development   direct view option award  pm na kite pharma inc kite kim helen susanevp business development   direct view exercise  pm nana kite pharma inc kite kim helen susanevp business development   direct view exercise  pm nana kite pharma inc kite kim helen susanevp business development   direct view option award  pm na kite pharma inc kite kim helen susanevp business development   direct view exercise  pm na kite pharma inc kite kim helen susanevp business development   direct view exercise  pm na kite pharma inc kite kim helen susanevp business development   direct view option award  pm nana kite pharma inc kite kim helen susanevp business development   direct view option award  pm na kite pharma inc kite kim helen susanevp business development   direct view option award  pm na sunesis pharmaceuticals inc snss kim helen susandirector   direct view   secformcom all rights reserved archives        tue  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  insider trading  insider transactions  form  your browser is no longer supported please upgrade your browser homenewsscreenermapsgroupsportfolioinsiderfuturesforexbacktestselite help login register latest insider trading  top insider trading recent week  top  owner trading recent week filter all transactions buy transactions sale transactions ticker owner relationship date transaction cost shares value  shares total sec form  kitekim helen susanevp business developmentjun option exercisejun   pmkitekim helen susanevp business developmentjun salejun   pmkitekim helen susanevp business developmentmay option exercisemay   pmkitekim helen susanevp business developmentmay salemay   pmkitekim helen susanevp business developmentapr option exerciseapr   pmkitekim helen susanevp business developmentapr saleapr   pmkitekim helen susanevp business developmentmar option exercisemar   amkitekim helen susanevp business developmentfeb option exercisemar   amkitekim helen susanevp business developmentfeb salemar   amkitekim helen susanevp business developmentmar salemar   amkitekim helen susanevp business developmentdec saledec   pmkitekim helen susanevp business developmentaug option exerciseaug   pmkitekim helen susanevp business developmentaug option exerciseaug   pmkitekim helen susanevp business developmentaug saleaug   pmkitekim helen susanevp business developmentaug saleaug   pm open in screener × upgrade your finviz experience join thousands of traders who make more informed decisions with our premium features realtime quotes advanced visualizations backtesting and much more learn more about finvizelite kim helen susan top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active kim helen susan • hayward ca how do i update this listing kim helen susan is based out of hayward whalewisdom has at least  insider transactions form  in our database for kim helen susan summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from kim helen susan enter your email address below and choose submit your email cancel contact info kim helen susan  bay center place hayward ca     business phone  sec sic codepharmaceutical preparations recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free kite pharma inc kite evp business development kim helen susans insider stock buys and sells home homepage membership levels membership data coverage complete stock list founders message the book free trial screeners value screens allinone screener industry overview ben graham netnet undervalued predictable buffettmunger screener magic formula greenblatt historical low ps list historical low pb list peter lynch screen high short interest weekyy lows weekyy highs predictable companies sp  grid dividend stocks spin off list downloads  tools excel addin guruf manual of stocks™ download financial data download guru portfolios download stock pdfs download insider data api mobile app strategies performances buffettmunger undervalued predictable low ps low pb broadest owned most weighted gurus latest guru picks real time picks list of gurus personalize gurus portfolios scoreboard top  holdings view sector picks international picks aggregated portfolio consensus picks guru bargains hot picks industry trends geographic trend etfs options european shorting insiders all insiders ceo buyssales cfo buyssales insider cluster guruinsider double buys triple buyssales insider trends canadian insider dutch insider market market valuation economic data industry overview marketcapgdp valuation global market valuation shiller pe shiller pe by sectors buffett assets allocation by country usa australia canada china germany india japan uk more articles articles editors picks gurufocus research value ideas interviews with gurus top ranked value idea contest videos following authors submit articles writers wanted value contest winners submit articles online my articles conference value conference speakers locationvenue register after conference gathering free drinks tutorials tutorials  webinars faq contact us log in free signup log in day free trial subscribe free trial year refer a friend  earn  search compare search ▾ get day free trial my portfolios▾ portfolios overview create new portfolio portfolio contest my gurus▾ quick browse personalize my gurus premium gurus premium plus investors summarycanadian dutch ceo buys cfo buys insider cluster buys double buys triple buys data export trend saved usa canada ukireland europe asia oceania latin america africa currently selected show all countries ▾ purchase to select this region purchase  usa otcpk nas nyse arca otcbb amex bats purchase to select this region purchase  canada tsxv tsx xcnq purchase to select this region purchase  ukireland uk purchase to select this region purchase  europe germany france poland russia sweden turkey bosnia and herzegovina italy luxembourg switzerland belgium greece norway spain denmark bulgaria netherlands romania finland serbia austria croatia portugal slovakia cyprus macedonia slovenia ukraine hungary lithuania latvia malta iceland estonia czech republic all countries ▾ purchase to select this region purchase  asia india japan korea thailand hongkong china taiwan malaysia singapore israel indonesia pakistan vietnam philippines sri lanka kuwait nepal saudi jordan oman iran iraq united arab emirates kazakhstan bahrain all countries ▾ purchase to select this region purchase  oceania australia new zealand purchase to select this region purchase  latin america brazil mexico argentina chile peru columbia jamaica venezuela ecuador purchase to select this region purchase  africa south africa egypt nigeria mauritius morocco zimbabwe kenya tunisia ghana côte divoire set as default insider trades try insider screener kite pharma inc kite evp business development kim helen susans insider stock buys and sellsto find out why gurufocus thinks data on insider trades is interesting read can aggregated insider trading activities predict the market stocks that both gurus and insiders are buying can aggregated insider trading activities predict the market of different sectors filter by   default search insider trade go select to drill down all market capmicro cap small cap mid cap large cap mega cap sp  companies all sectorsbasic materials consumer cyclical financial services real estate consumer defensive healthcare utilities communication services energy industrials technology display those with at least          shares display stocks that are within please select        of please select week lowyear lowyear lowreal time insider typebuysellinsider sentiment chart recent filings activity total records    page          last   per page ▾      symbol company insider position date buysell shares trade price  cost  price changesince trade  yield  pe market cap m details kitekite pharma inckim helen susanevp business dsell  link kitekite pharma inckim helen susanevp business dsell  link kitekite pharma inckim helen susanevp business dsell  link kitekite pharma inckim helen susanevp business dsell  link kitekite pharma inckim helen susanevp business dsell  link kitekite pharma inckim helen susanevp business dsell  link total records    page          last   per page ▾     add this list into my watchlistportfolio  add or remove tickers comma separated up to  symbols kite  select destination portfolioyou need to log in to proceed  click the button to finish related news and stories k comment on k k comment on k k comment on k k comment on k k kellogg co k chairman pres  ceotrustee john a bryant sold  million of shares k note of k k kellogg good stock for riskaverse investors k kellogg co k chairman pres  ceotrustee john a bryant sold  million of stocks k note of k k comment on k k comment on k k comment on k k comment on k k comment on k k note of k  only the transactions in open market or private sale at the market prices are included other transactions such as conversion of derivative security or exercise of options are not included insiders are limited to only officers andor directors of the company select portfolios create a new portfolio why you are interested your selection and notes will be stored in your portfolio login to add portfolio get wordpress plugins for easy affiliate links on stock tickers and guru names  earn affiliate commissions by embedding gurufocus charts gurufocus affiliate program earn up to  per referral  learn more home  about   jobs   advertise    site map    term of use    privacy policy     rss    mobile app     email alerts    referral program    affiliate program    faq    contact us      gurufocuscom llc all rights reserved disclaimers gurufocuscom is not operated by a broker a dealer or a registered investment adviser under no circumstances does any information posted on gurufocuscom represent a recommendation to buy or sell a security the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the gurus may buy and sell securities before and after any particular article and report and information herein is published with respect to the securities discussed in any article and report posted herein in no event shall gurufocuscom be liable to any member guest or third party for any damages of any kind arising out of the use of any content or other material published or available on gurufocuscom or relating to the use of or inability to use gurufocuscom or any content including without limitation any investment losses lost profits lost opportunity special incidental indirect consequential or punitive damages past performance is a poor indicator of future performance the information on this site and in its related newsletters is not intended to be nor does it constitute investment advice or recommendations the information on this site is in no way guaranteed for completeness accuracy or in any other way the gurus listed in this website are not affiliated with gurufocuscom llc stock quotes provided by interactive data fundamental company data provided by morningstar updated daily gf chat  please wait  seconds more okay online background checks  beenverified × beenverifiedcom looking to find out about someone so have the  people who have tried beenverified start here  try searching a friend relative date neighbor or even yourself people phone email property we respect your privacy first name last name state all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming   search phone number   search email address   search street address   search we respect your privacy  reports  counting background checks  public records  beenverified   × beenverifiedcom welcome to beenverified from beenverified on vimeo search people  public records try searching a friend relative or even yourself the choice is yours people phone email property we respect your privacy first name last name state all states alabama alaska arizona arkansas california colorado connecticut delaware district of columbia florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virginia washington west virginia wisconsin wyoming   search phone number   search email address   search street address   search   are you a business user try knowthycustomercom  successful people reports easy and affordable background checks learn why millions of people search beenverified unlimited searches anytime looking for someone our intuitive public records search engine makes it easy see our dos and donts affordable  accessible we dont want you to ask yourself if its worth it to run a search respect for privacy a privacyfriendly public record search is not an oxymoron learn how we do it public records in one easy report search for what you are looking for and get all the data we find in one single report learn about us beenverified for business imagine the power of beenverifieds massive public record database working for your business thats bv pro why bv pro enterprise apis perfect for teams batch processing customizable what is it for prevent fraud scrub records reach customers client relations try bv pro not sure check out our “do’s  don’ts” experience the beenverified difference see what people like you are saying about beenverified natasha oklahoma nursing student my daughter recently went out for soccer i decided it would be a good idea to run another player’s father through beenverified turns out this guy had been charged with indecent exposure and was on parole maryann new jersey analyst i used beenverified to check into a guy that i had met online it turns out he had lied to me about where he lived and his family needless to say thanks to bv i severed contact with him and have not heard from him since thank you bv bob m new jersey retired detective i am retired and have a ministry helping the dying and sick i found a son and the mother was dying of cancer she held on waiting for her son who had not been in touch for years rhonda missouri caring mom im a single mother dating online and i use beenverified to help protect my family more testimonials from the press gizmodocom it found my photos on flickr my amazon wishlist my public foursquare records vimeo picassa and stumbleupon accounts it grabbed approximately twelve bajillion photos of me with many many false positives and even more web links from the press us news  world report beenverified easily and inexpensively provides access to public records information through its website and several mobile phone applications no longer are large corporations the only ones who can afford background checks from the press nbc  miami instant information… court documents mortgage deeds criminal records right in the palm of your hand more press quotes billions of records at your fingertips with over  downloads so far beenverified is the goto choice for mobile public data access great app   beenverified is easy to use and provides the details needed for a reliable accurate background check highly recommend”  via the app store what are you waiting forsearch someone address lookup  property search  beenverifiedcom public data for personal matters questions  login every address tells a story search millions of property values deeds owners transactions and more search property records search millions of property values deeds owners transactions and more see who owns a property search millions of property values deeds owners transactions and more search mortgage records search millions of property values deeds owners transactions and more search property deeds search millions of property values deeds owners transactions and more every address tells a story search property owners records and more who owns this property search millions of property values deeds owners transactions and more start here  try searching your home your neighbors or another address address   search know the name of a property owner find out about them here search by owners name property data can help you find a home you will have access to data about property values sales prices loans deed history nearby sex offenders and much more connect with owners unlike other property websites beenverified will help you connect with the owners of every address go beyond the address your first property search opens the door to billions of public records about people places phone numbers and online identities the intersection of data and the real world beenverified helps you incorporate property records and public data into your life         reports run by users  b i l l i o n  public data points billions of records at your fingertips with over  downloads so far beenverified is the goto choice for mobile public data access incredibly simple to use and useful this app has saved the day on finding so many addresses i needed definitely recommend”   via the app store always improving beenverified is relentless in its pursuit of providing you with better public data search an address reverse property reverse address lookup search millions of property values deeds owners transactions and more start here try searching your home your neighbors or another address search we respect your privacy what makes us different property data  people data our reports include the traditional info you’d expect to find about a property ownership deeds tax info etc but we dig deeper and offer background records on people too find criminal background records on owners registered sex offenders in the neighborhood and more the extras we include for free run criminal background checks on previous owners their associates or the neighbors get to know the whole story know your new neighborhood by seeing sex offender information which may include names addresses and criminal convictions easy to use reporting just enter an address a name or even a phone number and we will give you all the information we have “excellent support  service”  via sitejabbercom  supportbeenverifiedcom mon  fri  am   pm estsat  sun  am   pm est our goal is to provide helpful support that is quick and easy carla director of customer service about us about bv people search testimonials careers leadership press white pages criminal records our apps all bv apps for iphone  ipad  download for apple watch  download for android  download developer api help support contact us dos  donts faq remove my info affiliates glossary disclaimer beenverified’s mission is to give people easy and affordable access to public record information beenverified does not provide private investigator services and is not a consumer reporting agency as defined by the fair credit report act because the information provided by beenverified is not collected or provided in whole or in part for the purpose of furnishing consumer reports about those search subjects for more information governing the permitted and prohibited uses of beenverified please review our “do’s  don’ts” and our terms  conditions beenverified   all rights reserved terms  conditions privacy policy